Status:
COMPLETED
Virtual Reality on the IMC
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Collaborating Sponsors:
University of Bern
Conditions:
Feasibility of Virtual Reality Stimulation for Critically Ill Patients
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this substudy (main study NCT04498585) is to determine the feasibility of applying virtual reality stimulation to patients in the intermediate care unit. Patients on this ward are generall...
Eligibility Criteria
Inclusion
- Written informed consent
- Aged ≥18 years
- No severe visual or auditory impairments (strabismus, macular degeneration, retinopathy)
- German or French speaking
- Estimated length of stay (from time of study inclusion) \>24 hours
Exclusion
- Patients without calotte, with external ventricular drainage or other Intracranial pressure probes
- Patients with epilepsy
- Patients with Covid-19
Key Trial Info
Start Date :
January 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05380700
Start Date
January 17 2022
End Date
May 31 2022
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inselspital
Bern, Switzerland, 1010